Clinical Trials Browser

KRAS Mutant Solid Tumors × pembrolizumab × Clear all

NCT07204340 2026-02-27

TLN-372 in Advanced KRAS Mutant Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

KRAS Mutant Solid Tumors